Samsung Bioepis ventures into novel R&D with Takeda deal

22nd August 2017 Uncategorised 0

Samsung Bioepis is joining forces with Takeda Pharmaceutical to jointly fund and co-develop multiple novel biologic therapies in unmet disease areas, taking its first step towards developing new pharmaceuticals.

More: Samsung Bioepis ventures into novel R&D with Takeda deal
Source: News